Download presentation
Presentation is loading. Please wait.
Published byTristan Labelle Modified over 6 years ago
1
Brain Radionecrosis Treated with Bevacizumab in a Patient with Resected Squamous Cell Carcinoma of the Lung Jordi Remon, MD, Cécile Le Péchoux, MD, Caroline Caramella, MD, Frederic Dhermain, MD, Guillame Louvel, MD, Jean-Charles Soria, MD, PhD, Benjamin Besse, MD, PhD Journal of Thoracic Oncology Volume 12, Issue 1, Pages e1-e3 (January 2017) DOI: /j.jtho Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions
2
Figure 1 Cerebral magnetic resonance imaging series (T1 sequence). Before bevacizumab (August 2015) (A), after three cycles of bevacizumab (B), after six cycles (C), and 2 months after bevacizumab was stopped (D). Journal of Thoracic Oncology , e1-e3DOI: ( /j.jtho ) Copyright © 2016 International Association for the Study of Lung Cancer Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.